FORMULARY DECISION
Conjugated oestrogens + Bazedoxifene : Duavive
1220/17 : Treatment of oestrogen deficiency symptoms in postmenopausal women with a uterus (with at least 12 months since the last menses) for whom treatment with progestin-containing therapy is not a...